FindTrial
Sign In

AI-based Novel Diabetes Classification

AI-based Novel Diabetes Classification and Prognostic Prediction in Korean cohort studies: a gateway to precision medicine in diabetes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009058
Enrollment
250
Registered
2023-12-19
Start date
2023-08-16
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: •Patients diagnosed with type 2 diabetes within the last 3 years •Age 19 and above, under 80

Exclusion criteria

Exclusion criteria: •Patients with type 1 diabetes •Those currently taking medications such as systemic steroids, obesity treatment drugs, or other medications that can affect current blood glucose levels •Patients deemed inappropriate for clinical research (e.g., pregnant individuals, severe systemic illnesses, mental disorders, etc.)

Design outcomes

Primary

MeasureTime frame
New diabetes subtype classification—

Secondary

MeasureTime frame
Diabetes-related outcomes—

Countries

Korea, Republic of

Contacts

Public ContactDa Young Lee

Korea University Ansan Hospital

ddkristin412@gmail.com+82-31-8099-6469

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026